Long-Term Persistence Follow-up Study to Evaluate the Immune Persistence of GSK Biologicals' Combined Hepatitis A / Hepatitis B Vaccine in Healthy Adult Volunteers.
Phase of Trial: Phase III
Latest Information Update: 19 Feb 2018
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary)
- Indications Hepatitis A; Hepatitis B
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 24 Nov 2011 Actual end date changed from Feb 2009 to Jan 2009 added as reported by ClinicalTrials.gov record.
- 25 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Sep 2008 New trial record.